申请人:Nissan Chemical Industries, Ltd.
公开号:EP1947101A1
公开(公告)日:2008-07-23
Compounds effective for preventing, treatment or improving diseases against which activation of the thrombopoietin receptor is effective are provided.
A compound represented by the formula (I) (wherein R1, R2, R3, L1, L2, X and Y are defined in the description), a tautomer, prodrug or pharmaceutically acceptable salt of the compound or a solvate thereof.
本发明提供了可有效预防、治疗或改善血栓生成素受体活化疾病的化合物。
由式(I)代表的化合物(其中 R1、R2、R3、L1、L2、X 和 Y 在描述中定义)、该化合物的同系物、原药或药学上可接受的盐或其溶液。